From regulated menstrual cycles to improved fertility, this FDA-registered OTC medication is the answer that millions have been anticipating.
Tampa, Florida, United States, 19th Jun 2025 - Women seeking scientifically validated solutions for hormonal balance and fertility enhancement now have a promising option on the horizon. Medicinal Technologies, a pioneering biopharmaceutical company based in the U.S., has announced its plans to release MEnera in late 2025. This innovative over-the-counter biologic is designed to tackle issues like menstrual irregularities, menopausal symptoms, PCOS, and infertility.
MEnera represents the culmination of years of research into small cell biologics, drawing inspiration from the groundbreaking Tejeda Equation, which identified key molecular contributors to conditions such as endometriosis. According to lead medical scientist Dr. Sheryene Tejeda, MEnera works by targeting the root causes of endocrine dysfunction, offering a pathway to restore hormonal balance without relying on synthetic compounds.
Dr. Tejeda emphasized that MEnera embodies a turning point in personal health, delivering genuine biological improvements supported by clinical science rather than superficial marketing claims. Women who struggle with hormonal imbalances, fatigue, low libido, poor egg quality, menopausal symptoms, irregular cycles, or fertility challenges can look forward to MEnera’s targeted solutions. The product is being made available at an accessible price point, backed by Medicinal Technologies’ commitment to scientific integrity and consumer safety. It will be distributed through local pharmacies across the U.S.
As an FDA-registered and closely supervised OTC drug targeting both endocrine and cellular levels, MEnera is the suitable choice for women coping with PCOS or contemplating conception and IVF procedures, grounded in comprehensive research rather than fleeting trends. Beyond its immediate impact, MEnera signifies a seminal moment for Medicinal Technologies, branching out into the realm of bespoke wellness and OTC therapeutics, serving as a beacon of hope in addressing unmet healthcare demands globally with empathy and specialized knowledge. A testament to the company’s extensive portfolio spanning from ophthalmology to women's health, Medicinal Technologies harnesses small cell biologic-driven innovations to develop game-changing accessible treatments, aiming to bridge the disconnect between cutting-edge research and tangible healing.
The launch of MEnera also signals a new chapter for Medicinal Technologies as the company delves into personalized wellness and over-the-counter therapeutics. Their approach combines cutting-edge medical research with a compassionate commitment to addressing global health challenges.
About Medicinal Technologies
Medicinal Technologies leverages advancements in small cell biologic science to deliver transformative therapies across areas such as ophthalmology and women’s health. The company’s mission centers on bridging innovative research with practical healing solutions to make impactful treatments accessible worldwide.
for media inquiries please contact:
Email: support@medicinaltechnologies.com
Phone: 1-833-363-6436
Media Contact
Organization: Medicinal Technologies
Contact Person: Public Relations
Website: https://medicinaltechnologies.com/
Email: Send Email
City: Tampa
State: Florida
Country:United States
Release id:29460
The post MEnera The Innovative OTC Biologic Revolutionizing Womens Reproductive Health appeared first on King Newswire. This content is provided by a third-party source.. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section above.
